Skip to main content

Table 2 LDL-C goal attainment rates in women and men, and the relative differences overall and by characteristics of the study population

From: Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy

 

Women (F)

Men (M)

Relative diff.(%) (M-W)/M*100%

Overall

46.0

53.8

14.5

Age

   

 <65

45.5

54.0

15.7

 <65> = 65

46.5

53.5

13.1

Educational level

   

 <65Primary middle school or lower

60.0

71.4

16.0

 <65High school and middle school

42.8

52.4

18.3

 Junior college or higher

49.8

56.5

11.9

Occupation

   

 Administrative

46.2

56.3

17.9

 Non-administrative

42.5

53.7

20.9

 Unemployed

46.8

51.7

9.5

Coverage rate of medical insurance

   

 0-69%

44.6

53.7

16.9

 ≥70%

46.8

53.8

13.0

Hospital level

   

 Tertiary

42.2

52.7

19.9

 Secondary

57.9

60.1

3.7

Co-morbidities

   

 CHD

34.3

49.7

31.0

 PAD

51.0

42.7

−19.4

 Stroke

39.1

50.0

21.8

 DM

31.5

43.9

28.2

 Hypertension

44.7

52.8

15.3

Obesity (BMI ≥ 28.0)

   

 Yes

40.7

47.2

13.8

 No

47.2

55.0

14.2

Currently smoking

   

 Yes

60.0

54.7

−9.7

 No

45.6

53.5

14.8

Family history of premature CHD

   

 Yes

36.4

45.0

19.1

 No

45.0

53.8

16.4

Risk stratification

   

 Low

87.3

94.8

7.9

 Moderate

76.3

75.5

−1.1

 High

45.7

57.3

20.2

 Very high

25.5

44.5

42.7

The dosage of statin treatment

   

     Low dose

34.4

48.9

29.7

     Standard dose

53.5

57.2

6.5

     High dose

55.9

52.3

−6.9

Diet modification

   

     Yes

46.3

54.3

14.7

     No

44.0

51.8

15.1

LDL-C (mmol/L) before therapy

   

     <3.37

56.4

60.2

6.3

     ≥3.37

37.7

42.8

11.9

  1. CHD, coronary heart disease; PAD, peripheral angiopathy disease; DM, diabetes mellitus; LDL-C, low-density lipoprotein cholesterol, HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; BMI, body mass index.